Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310 · see citing works

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326 · see citing works

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026 · see citing works

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 867 · see citing works

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 823 · see citing works

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777 · see citing works

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749 · see citing works

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698 · see citing works

Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study

Chen, H., Yuan, H., Gao, R., Zhang, J., Wang, D., Xiong, Y., Fan, G., Yang, F., Li, X., Zhou, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60111-2 · Cited by 648 · see citing works

Advances in the development of influenza virus vaccines

Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592 · see citing works

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

Smith, K., Garman, L., Wrammert, J., Zheng, N., Capra, J. D., Ahmed, R., & Wilson, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.3 · Cited by 471 · see citing works

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Ackerman, M. E., Moldt, B., Wyatt, R. T., Dugast, A., McAndrew, E. G., Tsoukas, S., Jost, S., Berger, C. T., Sciaranghella, G., Liu, Q., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.016 · Cited by 454 · see citing works

IMMUNITY TO INFLUENZA IN MAN

Couch, R. B., & Kasel, J. A. (1983) · Annual Review of Microbiology · doi:10.1146/annurev.mi.37.100183.002525 · Cited by 426 · see citing works

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

DiLillo, D. J., Palese, P., Wilson, P. C., & Ravetch, J. V. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84428 · Cited by 409 · see citing works

Characterization of H7N9 influenza A viruses isolated from humans

Watanabe, T., Kiso, M., Fukuyama, S., Nakajima, N., Imai, M., Yamada, S., Murakami, S., Yamayoshi, S., Iwatsuki‐Horimoto, K., Sakoda, Y., et al. (2013) · Nature · doi:10.1038/nature12392 · Cited by 399 · see citing works

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393 · see citing works

Influenza virus hemagglutinin stalk-based antibodies and vaccines

Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 327 · see citing works

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N. L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B. M., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. (2014) · Nature · doi:10.1038/nature13764 · Cited by 287 · see citing works

Signal transduction during Fc receptor-mediated phagocytosis

García-García, E., & Rosales, C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1092 · Cited by 249 · see citing works

Crosstalk between Human IgG Isotypes and Murine Effector Cells

Overdijk, M. B., Verploegen, S. A. B. W., Buijsse, A. O., Vink, T., Leusen, J. H. W., Bleeker, W. K., & Parren, P. W. H. I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200356 · Cited by 224 · see citing works

Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies

Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., Rose, R. D., Winnall, W. R., Stratov, I., Brööks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215 · see citing works

Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

Jegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 184 · see citing works

A common solution to group 2 influenza virus neutralization

Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M. A. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 180 · see citing works

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Margine, I., Palese, P., & Krammer, F. (2013) · Journal of Visualized Experiments · doi:10.3791/51112 · Cited by 169 · see citing works

A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum EfficacyIn Vivo

Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161 · see citing works

Tools to therapeutically harness the human antibody response

Wilson, P. C., & Andrews, S. F. (2012) · Nature reviews. Immunology · doi:10.1038/nri3285 · Cited by 146 · see citing works

A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine

Cox, R. J., Madhun, A. S., Hauge, S., Sjursen, H., Major, D., Kühne, M., Höschler, K., Saville, M. K., Vogel, F. R., Barclay, W., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.116 · Cited by 140 · see citing works

Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant

Mulligan, M. J., Bernstein, D. I., Winokur, P. L., Rupp, R. E., Anderson, E. J., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P. W., et al. (2014) · JAMA · doi:10.1001/jama.2014.12854 · Cited by 133 · see citing works

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains

Henry, C., Leon, P. E., Kaur, K., Tan, G. S., Zheng, N., Andrews, S., Huang, M., Qu, X., Huang, Y., Ferrer, M. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74374 · Cited by 127 · see citing works

Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses

Avnir, Y., Tallarico, A. S. C., Zhu, Q. K., Bennett, A. S., Connelly, G., Sheehan, J., Sui, J., Fahmy, A., Huang, C., Cadwell, G., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004103 · Cited by 127 · see citing works

Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin

Tan, G. S., Lee, P. S., Hoffman, R. M. B., Mazel‐Sanchez, B., Krammer, F., Leon, P. E., Ward, A. B., Wilson, I. A., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02289-14 · Cited by 119 · see citing works

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults

Karron, R. A., Talaat, K. R., Luke, C. J., Callahan, K. A., Thumar, B., DiLorenzo, S. C., McAuliffe, J. M., Schappell, E., Suguitan, A. L., Mills, K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.099 · Cited by 118 · see citing works

A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine

Couch, R. B., Patel, S. M., Wade-Bowers, C. L., & Niño, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049704 · Cited by 116 · see citing works

Crucial Role of Aspartic Acid at Position 265 in the CH2 Domain for Murine IgG2a and IgG2b Fc-Associated Effector Functions

Baudino, L., Shinohara, Y., Nimmerjahn, F., Furukawa, J., Nakata, M., Martínez-Soria, E., Petry, F., Ravetch, J. V., Nishimura, S., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6664 · Cited by 104 · see citing works

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

Talaat, K. R., Karron, R. A., Callahan, K. A., Luke, C. J., DiLorenzo, S. C., Chen, G. L., Lamirande, E. W., Jin, H., Coelingh, K. L., Murphy, B. R., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.082 · Cited by 90 · see citing works

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

Wohlbold, T. J., Chromikova, V., Tan, G. S., Meade, P. S., Amanat, F., Comella, P., Hirsh, A., & Krammer, F. (2015) · Journal of Virology · doi:10.1128/jvi.02275-15 · Cited by 81 · see citing works

Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets

Chen, Y., Baz, M., Lu, J., Paskel, M., Santos, C. P., Subbarao, K., Jin, H., & Matsuoka, Y. (2014) · Journal of Virology · doi:10.1128/jvi.00100-14 · Cited by 70 · see citing works

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine

Babu, T. M., Levine, M. Z., Fitzgerald, T. F., Luke, C. J., Sangster, M. Y., Jin, H., Topham, D. J., Katz, J. M., Treanor, J. J., & Subbarao, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.070 · Cited by 67 · see citing works

Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1

Jegaskanda, S., Laurie, K. L., Amarasena, T. H., Winnall, W. R., Kramski, M., De Rose, R., Barr, I. G., Brooks, A. G., Reading, P. C., & Kent, S. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit294 · Cited by 64 · see citing works

High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children

Terajima, M., Co, M. D. T., Cruz, J., & Ennis, F. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv181 · Cited by 61 · see citing works

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

Георгиевна, Р. Л., Kiseleva, I., Naykhin, A., Ерофеева, М. К., Stukova, M., Donina, S., Petukhova, G. D., Pisareva, M., Krivitskaya, V. Z., Grudinin, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087962 · Cited by 57 · see citing works

Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge

Krammer, F., Albrecht, R. A., Tan, G. S., Margine, I., Hai, R., Schmolke, M., Runstadler, J. A., Andrews, S. F., Wilson, P. C., Cox, R. J., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03095-13 · Cited by 54 · see citing works

Targeting B cell responses in universal influenza vaccine design

Kaur, K., Sullivan, M., & Wilson, P. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.08.007 · Cited by 53 · see citing works

Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013

Hu, J., Zhu, Y., Zhao, B., Li, J., Liu, L., Gu, K., Zhang, W., Su, H., Teng, Z., Tang, S., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.25.20838 · Cited by 53 · see citing works

Induction of Cross-Reactive Antibodies to Novel H7N9 Influenza Virus by Recombinant Newcastle Disease Virus Expressing a North American Lineage H7 Subtype Hemagglutinin

Goff, P. H., Krammer, F., Hai, R., Seibert, C. W., Margine, I., García‐Sastre, A., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.01085-13 · Cited by 52 · see citing works

An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans

Krammer, F., Jul‐Larsen, Å., Margine, I., Hirsh, A., Sjursen, H., Zambon, M. C. F. A., & Cox, R. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00272-14 · Cited by 52 · see citing works

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)

Sobhanie, M. M., Matsuoka, Y., Jegaskanda, S., Fitzgerald, T. F., Mallory, R. M., Chen, Y., Luke, C. J., Treanor, J. J., & Subbarao, K. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv526 · Cited by 51 · see citing works

High-Affinity H7 Head and Stalk Domain–Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine

Halliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45 · see citing works

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge

Schmeisser, F., Vasudevan, A., Verma, S., Wang, W., Alvarado-Facundo, E., Weiss, C. D., Atukorale, V. N., Meseda, C. A., & Weir, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117108 · Cited by 35 · see citing works

HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study

Gach, J. S., Achenbach, C. J., Chromikova, V., Berzins, B., Lambert, N., Landucci, G., Forthal, D. N., Katlama, C., Jung, B. H., & Murphy, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085371 · Cited by 27 · see citing works

Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus

He, F., Prabakaran, M., Tan, Y., Kartigayen, I., Kumar, S. R., & Kwang, J. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-219 · Cited by 25 · see citing works

An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13

Wohlbold, T. J., Hirsh, A., & Krammer, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.026 · Cited by 15 · see citing works

Predicating risk area of human infection with avian influenza A (H7N9) virus by using early warning model in China

李鹏媛, 顾豪高, 陆家海, 吴洛林, 张定梅, 郝元涛, 徐浩, 张王剑, & 郭貔 (2015) · doi:10.3760/cma.j.issn.0254-6450.2015.05.013 · Cited by 8 · see citing works

The human antibody response to influenza A virus infection and vaccination

Krammer, F. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 805 · see citing works

Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans

Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572 · see citing works

Natural polyreactive IgA antibodies coat the intestinal microbiota

Bunker, J. J., Erickson, S. A., Flynn, T. M., Henry, C., Koval, J., Meisel, M., Jabrì, B., Antonopoulos, D. A., Wilson, P. C., & Bendelac, A. S. (2017) · Science · doi:10.1126/science.aan6619 · Cited by 470 · see citing works

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa, P., Zhou, D., Dejnirattisai, W., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Nutalai, R., Tuekprakhon, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.033 · Cited by 460 · see citing works

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

Chen, Y.-Q., Wohlbold, T. J., Zheng, N., Huang, M., Huang, Y., Neu, K. E., Lee, J., Wan, H., Rojas, K. T., Roubidoux, E. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.030 · Cited by 419 · see citing works

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Pardi, N., Parkhouse, K., Kirkpatrick, E., McMahon, M., Zost, S. J., Mui, B. L., Tam, Y. K., Karikó, K., Barbosa, C. J., Madden, T. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05482-0 · Cited by 281 · see citing works

Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease

van Erp, E. A., Luytjes, W., Ferwerda, G., & van Kasteren, P. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00548 · Cited by 281 · see citing works

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Lee, J., Boutz, D. R., Chromikova, V., Joyce, M. G., Vollmers, C., Leung, K., Horton, A. P., DeKosky, B. J., Lee, C., Lavinder, J. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4224 · Cited by 278 · see citing works

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.003 · Cited by 262 · see citing works

Influenza Hemagglutinin Structures and Antibody RecognitionPreprint

Wu, N. C., & Wilson, I. A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038778 · Cited by 253 · see citing works

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2Preprint

Cathcart, A. L., Havenar‐Daughton, C., Lempp, F. A., Ma, D., Schmid, M., Agostini, M. L., Guarino, B., di Iulio, J., Rosen, L. E., Tucker, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.09.434607 · Cited by 206 · see citing works

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

Saphire, E. O., Schendel, S. L., Fusco, M. L., Gangavarapu, K., Gunn, B. M., Wec, A. Z., Halfmann, P. J., Brannan, J. M., Herbert, A. S., Qiu, X., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.033 · Cited by 212 · see citing works

Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses

Zhang, A., Stacey, H. D., Mullarkey, C. E., & Miller, M. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801149 · Cited by 195 · see citing works

Universal influenza virus vaccines and therapeutic antibodies

Nachbagauer, R., & Krammer, F. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.009 · Cited by 184 · see citing works

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 180 · see citing works

Systems serology detects functionally distinct coronavirus antibody features in children and elderly

Selva, K. J., van de Sandt, C. E., Lemke, M. M., Lee, C. Y., Shoffner, S. K., Chua, B. Y. L., Davis, S. K., Nguyen, T. H. O., Rowntree, L. C., Hensen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22236-7 · Cited by 172 · see citing works

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

Nachbagauer, R., Choi, A., Hirsh, A., Margine, I., Iida, S., Barrera, A., Marcela Ferrés, G., Albrecht, R. A., García‐Sastre, A., Bouvier, N. M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3684 · Cited by 172 · see citing works

Defining the risk of SARS-CoV-2 variants on immune protection

DeGrace, M. M., Ghedin, E., Frieman, M. B., Krammer, F., Grifoni, A., Alisoltani, A., Alter, G., Amara, R. R., Baric, R. S., Barouch, D. H., et al. (2022) · Nature · doi:10.1038/s41586-022-04690-5 · Cited by 167 · see citing works

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

He, W., Chen, C.-J., Mullarkey, C. E., Hamilton, J. R., Wong, C. K., Leon, P. E., Uccellini, M. B., Chromikova, V., Henry, C., Hoffman, K. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00928-3 · Cited by 166 · see citing works

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Junkins, R. D., Gallovic, M. D., Johnson, B. M., Collier, M. A., Watkins-Schulz, R., Cheng, N., David, C. N., McGee, C. E., Sempowski, G. D., Shterev, I. D., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.030 · Cited by 144 · see citing works

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Srivastava, K., Carreño, J. M., Gleason, C., Monahan, B., Singh, G., Abbad, A., Tcheou, J., Raskin, A. J., Kleiner, G., van Bakel, H., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.017 · Cited by 144 · see citing works

Antibody-mediated protection against Ebola virus

Saphire, E. O., Schendel, S. L., Gunn, B. M., Milligan, J. C., & Alter, G. (2018) · Nature Immunology · doi:10.1038/s41590-018-0233-9 · Cited by 134 · see citing works

Aging and influenza vaccine-induced immunity

Dugan, H. L., Henry, C., & Wilson, P. C. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103998 · Cited by 133 · see citing works

Tackling influenza with broadly neutralizing antibodies

Corti, D., Cameroni, E., Guarino, B., Kallewaard, N. L., Zhu, Q., & Lanzavecchia, A. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.002 · Cited by 133 · see citing works

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes

Wohlbold, T. J., Podolsky, K. A., Chromikova, V., Roubidoux, E. K., Falconieri, V., Meade, P. S., Amanat, F., Tan, J., tenOever, B. R., Tan, G. S., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0011-8 · Cited by 130 · see citing works

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

Leon, P. E., He, W., Mullarkey, C. E., Bailey, M. J., Miller, M. S., Krammer, F., Palese, P., & Tan, G. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613225113 · Cited by 118 · see citing works

Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans

Andrews, S. F., Joyce, M. G., Chambers, M. J., Gillespie, R. A., Kanekiyo, M., Leung, K., Yang, E. S., Tsybovsky, Y., Wheatley, A. K., Crank, M. C., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan2676 · Cited by 116 · see citing works

Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model

Bailey, M. J., Duehr, J. E., Dulin, H., Broecker, F., Brown, J. A., Arumemi, F., González, M. C. B., Leyva-Grado, V. H., Evans, M. J., Simon, V. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07008-0 · Cited by 106 · see citing works

Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination

Lindesmith, L. C., McDaniel, J. R., Changela, A., Verardi, R., Kerr, S. A., Costantini, V., Brewer-Jensen, P. D., Mallory, M. L., Voss, W. N., Boutz, D. R., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.007 · Cited by 104 · see citing works

Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9

Tarrahimofrad, H., Rahimnahal, S., Zamani, J., Jahangirian, E., & Aminzadeh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-03932-2 · Cited by 102 · see citing works

Immunosensor-based label-free and multiplex detection of influenza viruses: State of the art

Zhang, H., & Miller, B. L. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111476 · Cited by 100 · see citing works

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma

Natarajan, H., Crowley, A. R., Butler, S. E., Xu, S., Weiner, J. A., Bloch, E. M., Littlefield, K. E., Wieland‐Alter, W., Connor, R. I., Wright, P. F., et al. (2021) · mBio · doi:10.1128/mbio.00765-21 · Cited by 98 · see citing works

Is It Possible to Develop a “Universal” Influenza Virus Vaccine?Preprint

Krammer, F., García‐Sastre, A., & Palese, P. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028845 · Cited by 96 · see citing works

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Bootz, A., Karbach, A., Spindler, J., Kropff, B., Reuter, N., Sticht, H., Winkler, T., Britt, W. J., & Mach, M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006601 · Cited by 95 · see citing works

Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses

Guthmiller, J. J., Lan, L. Y.-L., Fernández‐Quintero, M. L., Han, J., Utset, H. A., Bitar, D. J., Hamel, N. J., Stovicek, O., Li, L., Tepora, M. E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.005 · Cited by 93 · see citing works

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

Chakraborty, S., Mallajosyula, V. V. A., Tato, C. M., Tan, G. S., & Wang, T. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.014 · Cited by 87 · see citing works

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

Dufloo, J., Grzelak, L., Staropoli, I., Madec, Y., Tondeur, L., Anna, F., Pelleau, S., Wiedemann, A., Planchais, C., Buchrieser, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100275 · Cited by 89 · see citing works

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

Creytens, S., Pascha, M. N., Ballegeer, M., Saelens, X., & de Haan, C. A. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.786617 · Cited by 89 · see citing works

Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Neu, K. E., Henry, C., & Wilson, P. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.012 · Cited by 87 · see citing works

Influenza and Antibody-Dependent Cellular Cytotoxicity

Holle, T. A. V., & Moody, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01457 · Cited by 83 · see citing works

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

Batty, C. J., Heise, M. T., Bachelder, E. M., & Ainslie, K. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.006 · Cited by 80 · see citing works

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

Asthagiri Arunkumar, G., Ioannou, A., Wohlbold, T. J., Meade, P., Aslam, S., Amanat, F., Ayllon, J., García-Sastre, A., & Krammer, F. (2019) · Journal of Virology · doi:10.1128/jvi.01696-18 · Cited by 80 · see citing works

Modulating Antibody Functionality in Infectious Disease and Vaccination

Gunn, B. M., & Alter, G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.002 · Cited by 80 · see citing works

First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

Guthmiller, J. J., Han, J., Li, L., Freyn, A. W., Liu, S. T. H., Stovicek, O., Stamper, C. T., Dugan, H. L., Tepora, M. E., Utset, H. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg4535 · Cited by 77 · see citing works

Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies

Ilinykh, P. A., Huang, K., Santos, R. I., Gilchuk, P., Gunn, B. M., Karim, M. M., Liang, J. Y.-J., Fouch, M. E., Davidson, E., Parekh, D. V., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.025 · Cited by 75 · see citing works

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

Jacobsen, H., Rajendran, M., Choi, A., Sjursen, H., Brokstad, K. A., Cox, R. J., Palese, P., Krammer, F., & Nachbagauer, R. (2017) · mBio · doi:10.1128/mbio.01463-17 · Cited by 73 · see citing works

Clinical and Immunological Characteristics of Human Infections With H5N6 Avian Influenza Virus

Bi, Y., Tan, S., Yang, Y., Wong, G., Zhao, M. J., Zhang, Q., Wang, Q., Zhao, X., Li, L., Yuan, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy681 · Cited by 73 · see citing works

Protective mechanisms of nonneutralizing antiviral antibodies

Chandler, T. L., Yang, A., Otero, C. E., Permar, S. R., & Caddy, S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011670 · Cited by 69 · see citing works

Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance

Chen, Y.-Q., Lan, L. Y.-L., Huang, M., Henry, C., & Wilson, P. C. (2018) · Journal of Virology · doi:10.1128/jvi.01526-18 · Cited by 69 · see citing works

Refined protocol for generating monoclonal antibodies from single human and murine B cells

Ho, I. Y., Bunker, J. J., Erickson, S. A., Neu, K. E., Huang, M., Cortese, M., Pulendran, B., & Wilson, P. C. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.09.001 · Cited by 68 · see citing works

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

Meade, P. S., Kuan, G. M., Strohmeier, S., Maier, H. E., Amanat, F., Balmaseda, Á., Ito, K., Roubidoux, E. K., Javier, A., Gresh, L., et al. (2020) · mBio · doi:10.1128/mbio.03243-19 · Cited by 67 · see citing works

Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens

Coughlan, L., Kremer, E. J., & Shayakhmetov, D. M. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.034 · Cited by 66 · see citing works

Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

Carreño, J. M., Alshammary, H., Singh, G., Raskin, A. J., Amanat, F., Amoako, A. A., Gonzalez-Reiche, A. S., van de Guchte, A., PARIS study group, Awawda, M. H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103626 · Cited by 61 · see citing works

Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection

de Vries, R. D., Nieuwkoop, N. J., Pronk, M., de Bruin, E., Leroux-Roels, G., Huijskens, E. G. W., van Binnendijk, R. S., Krammer, F., Koopmans, M. P. G., & Rimmelzwaan, G. F. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.082 · Cited by 63 · see citing works

Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain

Anderson, C., Ortega, S., Chaves, F. A., Knudsen-Clark, A. M., Yang, H., Topham, D. J., & DeDiego, M. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-14931-7 · Cited by 62 · see citing works

GII.4 Human Norovirus: Surveying the Antigenic Landscape

Mallory, M. L., Lindesmith, L. C., Graham, R. L., & Baric, R. S. (2019) · Viruses · doi:10.3390/v11020177 · Cited by 62 · see citing works

The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019

Yu, D., Xiang, G., Zhu, W., Lei, X., Li, B., Meng, Y., Yang, L., Jiao, H., Li, X., Huang, W., et al. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.21.1900273 · Cited by 61 · see citing works

Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

Moin, S. M., Boyington, J. C., Boyoglu-Barnum, S., Gillespie, R. A., Cerutti, G., Cheung, C. S., Cagigi, A., Gallagher, J. R., Brand, J., Prabhakaran, M. S., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.015 · Cited by 61 · see citing works

Harnessing immune history to combat influenza viruses

Guthmiller, J. J., & Wilson, P. C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.010 · Cited by 61 · see citing works

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin

Yu, F., He, S., Wu, Y., Chang, S. Y., Wang, L., Li, W., Hong, B., Xia, S., Wang, C., Khurana, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.08.011 · Cited by 60 · see citing works

The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens

Vanderven, H. A., & Kent, S. J. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12312 · Cited by 59 · see citing works

Immune Control of Avian Influenza Virus Infection and Its Vaccine Development

Dey, P., Ahuja, A., Panwar, J., Choudhary, P., Rani, S., Kaur, M., Sharma, A., Kaur, J. K., Yadav, A. K., Sood, V., et al. (2023) · Vaccines · doi:10.3390/vaccines11030593 · Cited by 63 · see citing works

Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein

Jegaskanda, S., Co, M. D. T., Cruz, J., Subbarao, K., Ennis, F. A., & Terajima, M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw629 · Cited by 58 · see citing works

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids

Cox, F., Kwaks, T., Brandenburg, B., Koldijk, M. H., Klaren, V., Smal, B., Korse, H. J. W. M., Geelen, E., Tettero, L., Zuijdgeest, D., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00399 · Cited by 57 · see citing works

Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic

Liu, W. J., Xiao, H., Dai, L., Liu, D., Chen, J., Qi, X., Bi, Y., Shi, Y., Gao, G. F., & Liu, Y. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0814-5 · Cited by 53 · see citing works

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies

Nakajima, R., Supnet, M., Jasinskas, A., Jain, A., Taghavian, O., Obiero, J. M., Milton, D. K., Chen, W. H., Grantham, M. L., Webby, R. J., et al. (2018) · mSphere · doi:10.1128/msphere.00592-18 · Cited by 52 · see citing works

Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model

Park, J.-K., Xiao, Y., Ramuta, M. D., Rosas, L. A., Fong, S. E., Matthews, L., Freeman, A. D., Gouzoulis, M. A., Batchenkova, N. A., Yang, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0937-x · Cited by 52 · see citing works

B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

Guthmiller, J. J., Utset, H. A., & Wilson, P. C. (2021) · Viruses · doi:10.3390/v13060965 · Cited by 52 · see citing works

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

Ilchmann, H., Samy, N., Reichhardt, D., Schmidt, D., Powell, J. D., Meyer, T. P. H., Silbernagl, G., Nichols, R., Weidenthaler, H., Moerlooze, L. D., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac455 · Cited by 51 · see citing works

Fc functional antibodies in humans with severe H7N9 and seasonal influenza

Vanderven, H. A., Liu, L., Ana‐Sosa‐Batiz, F., Nguyen, T. H. O., Wan, Y., Wines, B. D., Hogarth, P. M., Tilmanis, D., Reynaldi, A., Parsons, M. S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92750 · Cited by 51 · see citing works

Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans

Huang, K.-Y. A., Rijal, P., Jiang, H., Wang, B., Schimanski, L. M., Dong, T., Liu, Y.-M., Chang, P., Iqbal, M., Wang, M.-C., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0303-7 · Cited by 50 · see citing works

An Efficient Method to Generate Monoclonal Antibodies from Human B Cells

Guthmiller, J. J., Dugan, H. L., Neu, K. E., Lan, L. Y.-L., & Wilson, P. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8958-4_5 · Cited by 50 · see citing works

Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift

Luczo, J. M., & Spackman, E. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae014 · Cited by 49 · see citing works

Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function

Gao, R., Sheng, Z., Sreenivasan, C. C., Wang, D., & Li, F. (2020) · Viruses · doi:10.3390/v12030276 · Cited by 47 · see citing works

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses

Amanat, F., Duehr, J. E., Oestereich, L., Hastie, K. M., Saphire, E. O., & Krammer, F. (2018) · mSphere · doi:10.1128/msphere.00189-18 · Cited by 48 · see citing works

Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways

Jegaskanda, S., Vanderven, H. A., Tan, H., Alcântara, S., Wragg, K. M., Parsons, M. S., Chung, A. W., Juno, J. A., & Kent, S. J. (2018) · Journal of Virology · doi:10.1128/jvi.02090-18 · Cited by 48 · see citing works

Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design

Jegaskanda, S., Vanderven, H. A., Wheatley, A. K., & Kent, S. J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1290018 · Cited by 48 · see citing works

Effector mechanisms of influenza-specific antibodies: neutralization and beyond

Sicca, F., Neppelenbroek, S., & Huckriede, A. L. W. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1516553 · Cited by 47 · see citing works

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains

Turner, H. L., Pallesen, J., Lang, S., Bangaru, S., Urata, S. M., Li, S., Cottrell, C. A., Bowman, C. A., Crowe, J. E., Wilson, I. A., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000139 · Cited by 47 · see citing works

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

Clark, J. J., Hoxie, I., Adelsberg, D. C., Sapse, I. A., Andreata‐Santos, R., Yong, J. S., Amanat, F., Tcheou, J., Raskin, A. J., Singh, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114922 · Cited by 43 · see citing works

Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo

DiPiazza, A. T., Nogales, A., Poulton, N. C., Wilson, P. C., Martínez‐Sobrido, L., & Sant, A. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-11313-x · Cited by 43 · see citing works

Fatty Acid Metabolism is Associated With Disease Severity After H7N9 Infection

Sun, X., Song, L., Feng, S., Li, L., Yu, H., Wang, Q., Wang, X., Hou, Z., Li, X., Li, Y., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.019 · Cited by 43 · see citing works

Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges

Hu, Z., Liu, X., Jiao, X., & Liu, X. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.10.010 · Cited by 42 · see citing works

Non-neutralizing Antibodies Directed at Conservative Influenza Antigens

Sedova, E. S., Щербинин, Д. Н., Lysenko, A. A., Alekseeva, S. V., Artemova, E. A., & Шмаров, М. М. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-4-22-32 · Cited by 42 · see citing works

Strategies to induce broadly protective antibody responses to viral glycoproteins

Krammer, F. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1299576 · Cited by 41 · see citing works

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

Stadlbauer, D., Rajabhathor, A., Amanat, F., Kaplan, D., Masud, A., Treanor, J. J., Izikson, R., Cox, M. M. J., Nachbagauer, R., & Krammer, F. (2017) · mSphere · doi:10.1128/msphere.00502-17 · Cited by 41 · see citing works

Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies

Adachi, Y., Tonouchi, K., Nithichanon, A., Kuraoka, M., Watanabe, A., Shinnakasu, R., Asanuma, H., Ainai, A., Ohmi, Y., Yamamoto, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11821-6 · Cited by 41 · see citing works

Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults

Vanderven, H. A., Jegaskanda, S., Wines, B. D., Hogarth, P. M., Carmuglia, S., Rockman, S. P., Chung, A. W., & Kent, S. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix554 · Cited by 40 · see citing works

Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus

Jin, J., & Simmons, G. (2019) · Viruses · doi:10.3390/v11040305 · Cited by 40 · see citing works

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice

Bliss, C. M., Freyn, A. W., Caniels, T. G., Leyva-Grado, V. H., Nachbagauer, R., Sun, W., Tan, G. S., Gillespie, V., McMahon, M., Krammer, F., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.011 · Cited by 40 · see citing works

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk–Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity

de Vries, R. D., Nieuwkoop, N. J., van der Klis, F. R. M., Koopmans, M. P. G., Krammer, F., & Rimmelzwaan, G. F. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix546 · Cited by 39 · see citing works

Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response

Zolla‐Pazner, S., Powell, R. L. R., Yahyaei, S., Williams, C. A. U., Jiang, X., Li, W., Lu, S., Wang, S., Upadhyay, C., Hioe, C. E., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01403-16 · Cited by 39 · see citing works

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

Nachbagauer, R., Shore, D. A., Yang, H., Johnson, S. K., Gabbard, J. D., Tompkins, S. M., Wrammert, J., Wilson, P. C., Stevens, J., Ahmed, R., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00949-18 · Cited by 38 · see citing works

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections

Keeler, S. P., & Fox, J. M. (2021) · Viruses · doi:10.3390/v13061037 · Cited by 37 · see citing works

The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains

Nienen, M., Stervbo, U., Mölder, F., Kaliszczyk, S., Kuchenbecker, L., Gayova, L., Schweiger, B., Jürchott, K., Hecht, J., Neumann, A. U., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00593 · Cited by 37 · see citing works

The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza

Smith, A. M., & Huber, V. C. (2017) · Viral Immunology · doi:10.1089/vim.2017.0138 · Cited by 36 · see citing works

Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo

Epstein, S. L. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy145 · Cited by 36 · see citing works

Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection

Langel, S. N., Otero, C. E., Martinez, D. R., & Permar, S. R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008303 · Cited by 35 · see citing works

Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans

Liu, L., Nachbagauer, R., Zhu, L., Huang, Y., Xie, X., Jin, S., Zhang, A., Wan, Y., Hirsh, A., Tian, D., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw608 · Cited by 34 · see citing works

A Gene Constellation in Avian Influenza A (H7N9) Viruses May Have Facilitated the Fifth Wave Outbreak in China

Zhu, W., Dong, J., Zhang, Y., Yang, L., Li, X., Chen, T., Zhao, X., Wei, H., Bo, H., Zeng, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.081 · Cited by 34 · see citing works

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

Tan, G. S., Leon, P. E., Albrecht, R. A., Margine, I., Hirsh, A., Bahl, J., & Krammer, F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005578 · Cited by 147 · see citing works

An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans

Krammer, F., Jul‐Larsen, Å., Margine, I., Hirsh, A., Sjursen, H., Zambon, M. C. F. A., & Cox, R. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00272-14 · Cited by 52 · see citing works

RESEARCH ARTICLE Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge

Schmeisser, F., Vasudevan, A., Verma, S., Wang, W., Alvarado-Facundo, E., Weiss, C. D., Atukorale, V. N., Meseda, C. A., & Weir, J. P. (2016)

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge

Schmeisser, F., Vasudevan, A., Verma, S., Wang, W., Alvarado-Facundo, E., Weiss, C. D., Atukorale, V. N., Meseda, C. A., & Weir, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117108 · Cited by 35 · see citing works

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains

Henry, C., Leon, P. E., Kaur, K., Tan, G. S., Zheng, N., Andrews, S., Huang, M., Qu, X., Huang, Y., Ferrer, M. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74374 · Cited by 127 · see citing works